US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.92

+0.05001.74%

Post-market: 2.88-0.0400-1.37%19:40 EDT

Volume:329.56K

Turnover:933.32K

Market Cap:85.14M

PE:-1.75

High:2.94

Open:2.84

Low:2.70

Close:2.87

Loading ...

Overview Company News Filings

VistaGen Therapeutics Inc. to Announce Fiscal Year 2026 First Quarter Results

VistaGen Therapeutics Inc. Announces Date for 2025 Annual Meeting of Stockholders

VistaGen Therapeutics Appoints Elissa Cote as Chief Corporate Development Officer to Drive Strategic Growth

William Blair Reaffirms Their Buy Rating on VistaGen Therapeutics (VTGN)

VistaGen Therapeutics Q4 EPS $(0.44) Beats $(0.50) Estimate, Sales $(15.00K)

Vistagen reports FY25 EPS ($1.67), two estimates ($1.74)

VistaGen Therapeutics Reports Fiscal Year 2025 Results: Net Loss Widens to $51.4 Million, R&D Expenses Up Significantly

Press Release: Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

Calendar of U.S. Earnings Expected in the Week Ahead

Vistagen Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview

Press Release: Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

VistaGen Therapeutics Inc. to Announce Fiscal Year 2025 Financial Results

Vistagen Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview

BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial

VistaGen Therapeutics to Present at Jefferies 2025 Global Life Sciences Conference in New York

VistaGen Therapeutics Inc. to Present New Insights at the American Society of Clinical Psychopharmacology Conference

Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference

Vistagen to Present at the 2025 Anxiety and Depression Association Conference

Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VTGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":2.92,"timestamp":1754078400000,"preClose":2.87,"halted":0,"volume":329562,"hourTrading":{"tag":"盘后","latestPrice":2.88,"preClose":2.92,"latestTime":"19:40 EDT","volume":836,"amount":2420.4393,"timestamp":1754091656124},"delay":0,"floatShares":20459298,"shares":29157733,"eps":-1.66525,"marketStatus":"Market Closed","change":0.05,"latestTime":"08-01 16:00:00 EDT","open":2.84,"high":2.9403,"low":2.7,"amount":933319.5839999999,"amplitude":0.083728,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.66525,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":2.87,"preHourTrading":{"tag":"盘前","latestPrice":2.85,"preClose":2.87,"latestTime":"09:28 EDT","volume":2634,"amount":7427.9000184,"timestamp":1754054880754},"postHourTrading":{"tag":"盘后","latestPrice":2.88,"preClose":2.92,"latestTime":"19:40 EDT","volume":836,"amount":2420.4393,"timestamp":1754091656124},"volumeRatio":0.43624231267360236,"impliedVol":1.3305,"impliedVolPercentile":0.756},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":20459298,"roa":"-33.64%","roe":"-55.68%","lyrEps":-1.66525,"volumeRatio":0.43624231267360236,"shares":29157733,"dividePrice":0,"high":2.9403,"amplitude":0.083728,"preClose":2.87,"low":2.7,"week52Low":1.9,"pbRate":"1.21","psRate":"175.19","week52High":3.79,"institutionHeld":0,"latestPrice":2.92,"eps":-1.66525,"divideRate":0,"volume":329562,"delay":0,"ttmEps":-1.66525,"open":2.84,"prevYearClose":2.95,"prevWeekClose":3.08,"prevMonthClose":2.87,"prevQuarterClose":2,"fiveDayClose":3.08,"twentyDayClose":2,"sixtyDayClose":2.15,"earningDate":1754496000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555838022","title":"VistaGen Therapeutics Inc. to Announce Fiscal Year 2026 First Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2555838022","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555838022?lang=en_us&edition=fundamental","pubTime":"2025-07-31 20:30","pubTimestamp":1753965010,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will report its fiscal year 2026 first quarter results on August 7, 2025. The results will be released during a conference call and webcast at 2:00 p.m. Pacific Time . The webcast can be accessed through the Investors section of the Company's website under \"Events\". Interested participants can pre-register for the call via this link.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on July 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL7qmZP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2555701007","title":"VistaGen Therapeutics Inc. Announces Date for 2025 Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2555701007","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555701007?lang=en_us&edition=fundamental","pubTime":"2025-07-29 05:15","pubTimestamp":1753737321,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will hold its 2025 Annual Meeting of Stockholders virtually on September 9, 2025. The meeting will be conducted exclusively online. The Board of Directors has unanimously approved the proposals set forth in the proxy statement, and stockholders will be voting on these proposals during the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL8Czk36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2546521068","title":"VistaGen Therapeutics Appoints Elissa Cote as Chief Corporate Development Officer to Drive Strategic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2546521068","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546521068?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:30","pubTimestamp":1750854630,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc., a late clinical-stage biopharmaceutical company, has appointed Elissa Cote as Chief Corporate Development Officer. With nearly 30 years of experience in business development and global partnerships, Cote will focus on advancing Vistagen's clinical-stage pipeline, which includes five novel intranasal pherine candidates targeting six prevalent disorders. She will also lead the evaluation of strategic opportunities and cultivate prospective partnerships for the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL2fFS9Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2544924199","title":"William Blair Reaffirms Their Buy Rating on VistaGen Therapeutics (VTGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544924199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544924199?lang=en_us&edition=fundamental","pubTime":"2025-06-18 16:57","pubTimestamp":1750237059,"startTime":"0","endTime":"0","summary":"In a report released today, Myles Minter from William Blair reiterated a Buy rating on VistaGen Therapeutics (VTGN – Research Report). The company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN"],"gpt_icon":0},{"id":"2544463918","title":"VistaGen Therapeutics Q4 EPS $(0.44) Beats $(0.50) Estimate, Sales $(15.00K)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544463918","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544463918?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:41","pubTimestamp":1750192903,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Q4 EPS $(0.44) Beats $(0.50) Estimate, Sales $(15.00K)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/06/45985236/vistagen-therapeutics-q4-eps-0-44-beats-0-50-estimate-sales-15-00k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2544918421","title":"Vistagen reports FY25 EPS ($1.67), two estimates ($1.74)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544918421","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544918421?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:35","pubTimestamp":1750192520,"startTime":"0","endTime":"0","summary":"Reports FY25 revenue $486K vs. $1.06M last year. “This was a defining year for Vistagen (VTGN), marked by significant progress in our registration-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vistagen-reports-fy25-eps-1-67-two-estimates-1-74-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vistagen-reports-fy25-eps-1-67-two-estimates-1-74-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2544683918","title":"VistaGen Therapeutics Reports Fiscal Year 2025 Results: Net Loss Widens to $51.4 Million, R&D Expenses Up Significantly","url":"https://stock-news.laohu8.com/highlight/detail?id=2544683918","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544683918?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:30","pubTimestamp":1750192224,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc., a late clinical-stage biopharmaceutical company, reported its financial results for the fiscal year ended March 31, 2025. The company reported a net loss of $51.4 million for the year, compared to a net loss of $29.4 million for the previous fiscal year. Research and development expenses increased significantly to $39.4 million from $20.0 million, driven by expenses related to the U.S. registration-directed PALISADE Program for fasedienol in social anxiety disorder and U.S. IND-enabling program for PH80 in women's health. General and administrative expenses also rose to $17.1 million from $14.1 million, primarily due to increased headcount and consulting fees. As of March 31, 2025, VistaGen's cash, cash equivalents, and marketable securities totaled $80.5 million. The company is making progress in its clinical programs, with topline results of the PALISADE-3 Phase 3 Trial for fasedienol in social anxiety disorder expected in the fourth quarter of 2025 and PA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDLbRg5LX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"VistaGen Therapeutics Reports Fiscal Year 2025 Results: Net Loss Widens to $51.4 Million, R&D Expenses Up Significantly","news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2544391857","title":"Press Release: Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2544391857","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544391857?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:30","pubTimestamp":1750192200,"startTime":"0","endTime":"0","summary":"Topline results of PALISADE-3 Phase 3 Trial of fasedienol for acute treatment of social anxiety disorder expected in the fourth quarter of this year. PALISADE-4 Phase 3 Trial topline results expected in the first half of 2026. Company showcases promising clinical-stage pipeline of five novel intranasal pherine candidates targeting six highly prevalent and underserved disorders. Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today reported financial results for its fiscal year ended March 31, 2025, and provided a corporate update.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4232","BK4022","R","BK4139"],"gpt_icon":0},{"id":"2543675374","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675374?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:00","pubTimestamp":1750068000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Beyond Air Inc.                                 4Q      (.12)  4:05 PM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","IE0004445015.USD","BK4567","JBL","APOG","BK4112","KFY","LU1169589451.USD","LU1571399168.USD","LU2294711713.HKD","LU2133065610.SGD","FDS","GMS","BK4145","LU1989772840.SGD","LU0648001328.SGD","RNW","BK4007","BK4082","KBH","ACN","LU0545039389.USD","AMC","SG9999004303.SGD","LU2095319765.USD","KR","ACB","LU0868494617.USD","VTGN","LU0154245756.USD","AIOT","DRI","CMC","BK4588","BK4559","LEN","MEI","LEN.B","XAIR","SG9999014898.SGD","LU0267386448.USD","KMX","LZB","BK4088","BK4157","LU2210149790.SGD","LU0289739343.SGD","BK4139","LU1116320737.USD","LU2249611893.SGD"],"gpt_icon":0},{"id":"2543374186","title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2543374186","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543374186?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:10","pubTimestamp":1749845407,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of50cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a rise in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nL8N3SG217:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2542417511","title":"Press Release: Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542417511","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542417511?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:32","pubTimestamp":1749731520,"startTime":"0","endTime":"0","summary":"Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Tuesday, June 17, 2025, at 2:00 p.m. Pacific Time  to report results for its fiscal year 2025 ended March 31, 2025, and provide a corporate update.The conference call is being webcast live, and a link can be found under \"Events\" in the Investors section of the Company's website. Participants may register to join the live call by following the link here to receive the dial-in numbers and unique PIN to access the call. Those who plan on participating are advised to join 15 minutes prior to the start time. A webcast replay of the call will be available on Vistagen's website about 24 hours after the end of the live conference call and will be accessible for at least 30 days.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN","BK4585","BK4588","BK4181","BK4218","HST"],"gpt_icon":0},{"id":"2542511156","title":"VistaGen Therapeutics Inc. to Announce Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2542511156","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542511156?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:30","pubTimestamp":1749731414,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will report its fiscal year 2025 financial results on June 17, 2025. The results will be released via a conference call and webcast at 2:00 p.m. Pacific Time . Participants can register to join the live call by following the link to receive the dial-in numbers and unique PIN to access the call. A webcast replay will be available on Vistagen's website about 24 hours after the live conference call and will be accessible for at least 30 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL8Q5STP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2541898448","title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2541898448","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541898448?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:12","pubTimestamp":1749240726,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of50cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a rise in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nL5N3S91F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2540284798","title":"BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540284798","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540284798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:35","pubTimestamp":1748867754,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 TrialJune 2 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN ON TRACK TO DELIVER TOPLINE DATA FROM FASEDIENOL PA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUABK56ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2538476865","title":"VistaGen Therapeutics to Present at Jefferies 2025 Global Life Sciences Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2538476865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538476865?lang=en_us&edition=fundamental","pubTime":"2025-05-28 20:30","pubTimestamp":1748435457,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc., a late clinical-stage biopharmaceutical company, is set to present at the Jefferies 2025 Global Life Sciences Conference in New York. The company's President and CEO, Shawn Singh, will participate in a fireside chat on Thursday, June 5, at 11:40 a.m. Eastern Time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL9QcHGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2537139619","title":"VistaGen Therapeutics Inc. to Present New Insights at the American Society of Clinical Psychopharmacology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2537139619","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537139619?lang=en_us&edition=fundamental","pubTime":"2025-05-23 20:30","pubTimestamp":1748003428,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will present at the American Society of Clinical Psychopharmacology Conference in Scottsdale, Arizona, from May 27-30, 2025. The company will showcase poster presentations exploring the age of onset of social anxiety disorder from fasedienol clinical trials and the impact of itruvone on nasal chemosensory receptors and the olfactory bulb, which are biomarkers of its effect on nasal chemosensory neurons and olfactory bulb activation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL9VZTBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2528971440","title":"Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2528971440","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528971440?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"New Data Build on Recent Epidemiology Findings Presented by the Company at the 2024 Neuroscience Education Institute Congress. The Need for Improved Diagnosis and Treatment Options Underscored by Data Presented in Posters. \"This new research provides a clearer and more comprehensive picture of social anxiety disorder — shining light on its rising prevalence and significant impact on young adults,\" said Ross Baker, Ph.D., MBA, Vice President, Medical Strategy at Vistagen and a co-author of the research. \"Existing therapies remain limited, and these findings reinforce the urgent need for new treatment options. The new research also highlights the critical role of timely diagnosis to improve patient outcomes.\". The key findings from the poster presentations by Vistagen at the ADAA and NEI conferences reveal important insights into SAD, including:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-presents-research-impact-social-123000130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2520518145","title":"Vistagen to Present at the 2025 Anxiety and Depression Association Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2520518145","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520518145?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387400,"startTime":"0","endTime":"0","summary":"Posters Highlight New Insights into Social Anxiety Disorder. SOUTH SAN FRANCISCO, Calif., March 19, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will present at the Anxiety and Depression Association of America  Conference in Las Vegas, Nevada from April 3 to 5, 2025. The Company’s poster presentations will explore the age of onset of social anxiety disorder  from participants in fasedienol clinical trials, and new data on the characteristics of young adults with and without SAD.Date: Saturday, April 5, 2025, 5:00 p.m. Eastern TimeTitle: Social Anxiety Disorder among Young Adults : A Cross-Sectional Study Using Data from the US National Health and Wellness SurveyAuthors: Ross A. Baker, PhD; Josh Prince; Nikoletta Sternbach; Soohyun Hwang, PhD, MPHPoster Number: S109. This press release contains certain f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-present-2025-anxiety-depression-123000467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2516467905","title":"Vistagen to Participate in Stifel 2025 Virtual CNS Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467905","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467905?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., March 04, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced that management will participate in Stifel’s 2025 Virtual CNS Forum.Vistagen’s President and Chief Executive Officer, Shawn Singh, will participate in a fireside chat presentation on Tuesday, March 18, 2025, at 12 p.m. Eastern Time. A live webcast will be accessible through the \"Events\" page in the \"Investors\" section of the Company’s website at www.Vistagen.com. A replay of the webcast will be archived and available following the event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-participate-stifel-2025-virtual-133000498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNS","BK4127","SF","BK4139","FET","VTGN","BK4135","BK4179"],"gpt_icon":1},{"id":"2511710946","title":"Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511710946","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511710946?lang=en_us&edition=fundamental","pubTime":"2025-02-15 20:33","pubTimestamp":1739622823,"startTime":"0","endTime":"0","summary":"NasdaqCM:VTGN Earnings and Revenue History February 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 31%. Earnings per share  also surpassed analyst estimates by 9.8%.Looking ahead, revenue is forecast to grow 65% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 5.7% from a week ago.You still need to take note of risks, for example - Vistagen Therapeutics has   3 warning signs    we think you should know about.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-third-quarter-2025-123343743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"VTGN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.47,"defaultRemindTime":1754596800000,"name":null,"time":"Post Market","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-06-17","symbol":"VTGN","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1750132800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-11-07","symbol":"VTGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-13","symbol":"VTGN","fiscalQuarterEnding":"2024/06","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1701921600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2025-07-31","current":-1.672864,"percent":0.666124,"low":-37.785134,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"high":-0.195082,"avg":-6.981879,"sd":9.180944,"marketCap":86015312},"quantilePoints":[{"date":"2020-08-07","current":-3.089651,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":64184406},{"date":"2020-08-14","current":-3.162221,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":55942531},{"date":"2020-08-21","current":-2.87737,"twenty":-2.145804,"median":-1.438446,"eighty":-0.742724,"marketCap":50903263},{"date":"2020-08-28","current":-2.887409,"twenty":-2.152145,"median":-1.438446,"eighty":-0.742724,"marketCap":51080858},{"date":"2020-09-04","current":-2.541907,"twenty":-2.160117,"median":-1.438446,"eighty":-0.742724,"marketCap":44968619},{"date":"2020-09-11","current":-2.562821,"twenty":-2.168669,"median":-1.438446,"eighty":-0.742724,"marketCap":45338609},{"date":"2020-09-18","current":-2.695417,"twenty":-2.17444,"median":-1.438446,"eighty":-0.742724,"marketCap":47684347},{"date":"2020-09-25","current":-2.57286,"twenty":-2.180777,"median":-1.438446,"eighty":-0.742724,"marketCap":45516204},{"date":"2020-10-02","current":-3.061833,"twenty":-2.188503,"median":-1.438446,"eighty":-0.742724,"marketCap":54166577},{"date":"2020-10-09","current":-3.11621,"twenty":-2.200038,"median":-1.438446,"eighty":-0.742724,"marketCap":55128552},{"date":"2020-10-16","current":-3.413609,"twenty":-2.205567,"median":-1.438446,"eighty":-0.742724,"marketCap":60389814},{"date":"2020-10-23","current":-3.281431,"twenty":-2.216002,"median":-1.438446,"eighty":-0.742724,"marketCap":58051475},{"date":"2020-10-30","current":-2.992398,"twenty":-2.228727,"median":-1.438446,"eighty":-0.742724,"marketCap":52938209},{"date":"2020-11-06","current":-2.823411,"twenty":-2.235372,"median":-1.440595,"eighty":-0.742724,"marketCap":49948688},{"date":"2020-11-13","current":-3.309225,"twenty":-2.243769,"median":-1.447362,"eighty":-0.742724,"marketCap":51798639},{"date":"2020-11-20","current":-3.358391,"twenty":-2.251548,"median":-1.461665,"eighty":-0.742724,"marketCap":52568219},{"date":"2020-11-27","current":-3.640148,"twenty":-2.258433,"median":-1.467237,"eighty":-0.742724,"marketCap":56978503},{"date":"2020-12-04","current":-3.630693,"twenty":-2.266793,"median":-1.47671,"eighty":-0.742724,"marketCap":56830507},{"date":"2020-12-11","current":-3.474686,"twenty":-2.279445,"median":-1.498443,"eighty":-0.742724,"marketCap":54388571},{"date":"2020-12-18","current":-11.903133,"twenty":-2.291259,"median":-1.520919,"eighty":-0.742724,"marketCap":186317357},{"date":"2020-12-24","current":-12.212852,"twenty":-2.309867,"median":-1.543115,"eighty":-0.742724,"marketCap":191165325},{"date":"2020-12-31","current":-17.084132,"twenty":-2.322388,"median":-1.548046,"eighty":-0.742724,"marketCap":267414498},{"date":"2021-01-08","current":-19.10957,"twenty":-2.333493,"median":-1.548046,"eighty":-0.742724,"marketCap":299118279},{"date":"2021-01-15","current":-21.221638,"twenty":-2.351108,"median":-1.548046,"eighty":-0.742724,"marketCap":332178060},{"date":"2021-01-22","current":-19.541592,"twenty":-2.35963,"median":-1.548046,"eighty":-0.742724,"marketCap":305880630},{"date":"2021-01-29","current":-18.74578,"twenty":-2.377597,"median":-1.548046,"eighty":-0.742724,"marketCap":293423953},{"date":"2021-02-05","current":-17.949969,"twenty":-2.395255,"median":-1.548046,"eighty":-0.742724,"marketCap":280967275},{"date":"2021-02-12","current":-18.054458,"twenty":-2.424455,"median":-1.548046,"eighty":-0.742724,"marketCap":270636328},{"date":"2021-02-19","current":-27.979684,"twenty":-2.444135,"median":-1.559823,"eighty":-0.742724,"marketCap":419415462},{"date":"2021-02-26","current":-23.347912,"twenty":-2.449711,"median":-1.559823,"eighty":-0.742724,"marketCap":349985200},{"date":"2021-03-05","current":-20.134029,"twenty":-2.470472,"median":-1.558206,"eighty":-0.742674,"marketCap":301809099},{"date":"2021-03-12","current":-22.2136,"twenty":-2.499151,"median":-1.561745,"eighty":-0.742674,"marketCap":332981870},{"date":"2021-03-19","current":-22.471645,"twenty":-2.519736,"median":-1.561745,"eighty":-0.742674,"marketCap":336849963},{"date":"2021-03-26","current":-20.559165,"twenty":-2.555481,"median":-1.563666,"eighty":-0.742724,"marketCap":308181881},{"date":"2021-04-01","current":-20.941661,"twenty":-2.570852,"median":-1.563666,"eighty":-0.742724,"marketCap":313915497},{"date":"2021-04-09","current":-20.654789,"twenty":-2.606601,"median":-1.561745,"eighty":-0.742674,"marketCap":309615285},{"date":"2021-04-16","current":-19.602925,"twenty":-2.636028,"median":-1.561745,"eighty":-0.742674,"marketCap":293847840},{"date":"2021-04-23","current":-19.507301,"twenty":-2.644829,"median":-1.561745,"eighty":-0.742674,"marketCap":292414436},{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726},{"date":"2025-06-20","current":-1.168169,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":60064929},{"date":"2025-06-27","current":-1.162499,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":59773352},{"date":"2025-07-03","current":-1.134145,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":58315466},{"date":"2025-07-11","current":-1.377986,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":70853291},{"date":"2025-07-18","current":-1.440364,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":74060641},{"date":"2025-07-25","current":-1.536766,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":79017456},{"date":"2025-07-31","current":-1.672864,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":86015312}],"updateTime":1754102115893}}}